journal article·2019-12-04Open access

Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451

Bin Liu, Wei Cao, Hui Ma

Abstract

Background Glioma is a main cause of brain-cancer relevant death. The present paper designed to reveal the possible role of LSINCT5 in human glioma GL15 cells.Methods LSINCT5 and miR-451 expression in glioma tissues was examined using qRT-PCR. The impacts of LSINCT5, miR-451 and Rac1 in GL15 cells were checked by carrying out CCK-8 assay, transwell assay, and flow cytometric analysis. Further, the target gene of LSINCT5 and miR-451 was explored. Accumulation of PI3K/AKT, Wnt/β-catenin and NF-κB pathway proteins was examined using Western blot.Results LSINCT5 was highly expressed while miR-451 low expressed in glioma tissues when compared to normal controls. Down-regulating LSINCT5 effectively declined GL15 cells viability, migration and invasion, but accelerated apoptosis. Nonetheless, the above-mentioned effects of LSINCT5 down-regulation were weakened when miR-451 was silenced. Rac1 was a target of miR-451. The tumour-suppressive effects of miR-451 on GL15 cells were weakened when Rac1 was overexpressed. Further, LSINCT5-miR-451-Rac1 axis could impact the activation of PI3K/AKT, Wnt/β-catenin and NF-κB pathways.Conclusion Down-regulation of LSINCT5 represses glioma cells growth and metastasis in vitro likely through targeting miR-451 and thereby inhibiting Rac1-regulated PI3K/AKT, Wnt/β-catenin and NF-κB pathways.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · RNA modifications and cancer · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurosurgery, Jining No.1 People’s Hospital

References (40)

Show source-provided references
1. 10.1016/j.biopha.2017.06.05810.1016/j.biopha.2017.06.058 ↗
2. 10.1186/s13046-016-0367-210.1186/s13046-016-0367-2 ↗
3. 10.1007/s13277-014-2262-910.1007/s13277-014-2262-9 ↗
4. 10.1155/2017/724396810.1155/2017/7243968 ↗
5. 10.1158/2159-8290.CD-11-020910.1158/2159-8290.CD-11-0209 ↗
6. 10.1093/hmg/ddm33610.1093/hmg/ddm336 ↗
7. 10.1158/1538-7445.NONRNA12-A110.1158/1538-7445.NONRNA12-A1 ↗
8. 10.1097/MD.000000000000030310.1097/MD.0000000000000303 ↗
9. 10.4161/rna.8.3.1480010.4161/rna.8.3.14800 ↗
10. 10.3892/mmr.2015.424710.3892/mmr.2015.4247 ↗
11. 10.1080/15384101.2015.112091710.1080/15384101.2015.1120917 ↗
12. 10.1016/j.cell.2011.12.00310.1016/j.cell.2011.12.003 ↗
13. 10.2741/395210.2741/3952 ↗
14. 10.1002/emmm.20110020910.1002/emmm.201100209 ↗
15. Tian Y, Nan Y, Han LEI, et al. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol. 2012;40:1105–1112.
16. 10.1371/journal.pone.010190310.1371/journal.pone.0101903 ↗
17. 10.1016/j.molcel.2010.02.01810.1016/j.molcel.2010.02.018 ↗
18. 10.1089/humc.2018.13310.1089/humc.2018.133 ↗
19. 10.3892/ijo.2017.397310.3892/ijo.2017.3973 ↗
20. 10.4161/cc.9.14.1224810.4161/cc.9.14.12248 ↗
21. 10.1016/j.brainres.2010.08.07410.1016/j.brainres.2010.08.074 ↗
22. 10.1371/journal.pone.002829310.1371/journal.pone.0028293 ↗
23. 10.1016/bs.vh.2017.03.00210.1016/bs.vh.2017.03.002 ↗
24. 10.1158/0008-5472.CAN-05-421110.1158/0008-5472.CAN-05-4211 ↗
25. 10.2147/OTT.S6799810.2147/OTT.S67998 ↗
26. 10.1172/JCI5884910.1172/JCI58849 ↗
27. 10.1158/0008-5472.CAN-12-095310.1158/0008-5472.CAN-12-0953 ↗
28. 10.18632/oncotarget.796110.18632/oncotarget.7961 ↗
29. 10.18869/acadpub.rmm.4.3.1710.18869/acadpub.rmm.4.3.17 ↗
30. 10.1002/ijc.2948410.1002/ijc.29484 ↗
31. 10.1038/onc.2011.22310.1038/onc.2011.223 ↗
32. 10.1093/carcin/bgt20610.1093/carcin/bgt206 ↗
33. 10.4161/sgtp.2901910.4161/sgtp.29019 ↗
34. Senger DL, Tudan C, Guiot MC, et al. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes. Cancer Res. 2002;62:2131.
35. 10.1016/j.celrep.2014.10.05510.1016/j.celrep.2014.10.055 ↗
36. 10.1158/1535-7163.MCT-13-016410.1158/1535-7163.MCT-13-0164 ↗
37. 10.1016/j.stem.2013.04.00610.1016/j.stem.2013.04.006 ↗
38. 10.18632/oncotarget.1361810.18632/oncotarget.13618 ↗
39. 10.4161/cbt.2008210.4161/cbt.20082 ↗
40. 10.1159/00049225510.1159/000492255 ↗